Cascadian Therapeutics, Inc. Share-based Payment Arrangement, Expense
Cascadian Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of $3.20 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2018-03-08
- Cascadian Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2017-12-31 was $800.00K, a 300.00% increase year-over-year.
- Cascadian Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2017-09-30 was $700.00K, a 0.00% change year-over-year.
- Cascadian Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2017-06-30 was $1.00M, a 0.00% change year-over-year.
- Cascadian Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2017-03-31 was $700.00K, a 75.86% decline year-over-year.
- Cascadian Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2017 was $3.20M, a 33.33% decline from fiscal 2016.
- Cascadian Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2016 was $4.80M, a 128.57% increase from fiscal 2015.
- Cascadian Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2015 was $2.10M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2017-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $1.50M derived: sum of 2 quarters · filed 2018-03-08 | $2.50M derived: sum of 3 quarters · filed 2018-03-08 | $3.20M 10-K · filed 2018-03-08 | ||
| 2017-09-30 | $700.00K 10-Q · filed 2017-11-08 | $1.70M derived: sum of 2 quarters · filed 2017-11-08 | $2.40M 10-Q · filed 2017-11-08 | $2.60M derived: sum of 4 quarters · filed 2018-03-08 | ||
| 2017-06-30 | $1.00M 10-Q · filed 2017-08-08 | $1.70M 10-Q · filed 2017-08-08 | $1.90M derived: sum of 3 quarters · filed 2018-03-08 | $2.60M derived: sum of 4 quarters · filed 2018-03-08 | ||
| 2017-03-31 | $700.00K 10-Q · filed 2017-05-09 | $900.00K derived: sum of 2 quarters · filed 2018-03-08 | $1.60M derived: sum of 3 quarters · filed 2018-03-08 | $2.60M derived: sum of 4 quarters · filed 2018-03-08 | ||
| 2016-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $900.00K derived: sum of 2 quarters · filed 2018-03-08 | $1.90M derived: sum of 3 quarters · filed 2018-03-08 | $4.80M 10-K · filed 2018-03-08 | ||
| 2016-09-30 | $700.00K 10-Q · filed 2017-11-08 | $500.00K 10-Q · filed 2016-11-07 | $1.70M derived: sum of 2 quarters · filed 2017-11-08 | $4.60M 10-Q · filed 2017-11-08 | $4.10M 10-Q · filed 2016-11-07 | $5.40M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $1.00M 10-Q · filed 2017-08-08 | $3.80M 10-Q · filed 2017-08-08 | $4.70M derived: sum of 3 quarters · filed 2018-03-08 | $5.20M derived: sum of 4 quarters · filed 2018-03-08 | ||
| 2016-03-31 | $2.90M 10-Q · filed 2017-05-09 | $200.00K 10-Q · filed 2016-05-09 | $3.70M derived: sum of 2 quarters · filed 2018-03-08 | $4.20M derived: sum of 3 quarters · filed 2018-03-08 | ||
| 2015-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $1.30M derived: sum of 2 quarters · filed 2018-03-08 | $2.10M 10-K · filed 2018-03-08 | |||
| 2015-09-30 | $500.00K 10-Q · filed 2016-11-07 | $1.30M 10-Q · filed 2016-11-07 | ||||
| 2015-03-31 | $1.50K 10-Q · filed 2016-05-09 | |||||
| 2014-03-31 | $287.00K 10-Q · filed 2015-05-11 |